Objective To estimate the impact of glycaemic control and time since diabetes diagnosis on care costs incurred by people with type 2 diabetes mellitus (T2DM). Research design and methods Random-effects linear regression models were run to test the impact of average glucose control (HbA1c) and time since diabetes diagnosis on total care spending in people with T2DM, adjusting for year of onset and other covariates. Two datasets were linked, Vektis (healthcare costs reimbursed by the Dutch mandatory health insurance) and Zodiac (clinical and sociodemographic data). The sample includes 22,612 observations, grouped in 5653 individuals from the Northern part of the Netherlands, covering 4 years (2008-2011). Results A 1% point increase in HbA1c i...
Aim: To analyse how healthcare utilisation, healthcare costs and health-related quality of life (HRQ...
We estimated healthcare costs associated with patients with type 2 diabetes compared with non-diabet...
Background: Type 2 diabetes mellitus is a common, chronic, and costly disease, and its prevalence is...
Objective To estimate the impact of glycaemic control and time since diabetes diagnosis on care cost...
Abstract Background The objective of this research is to quantify the association between direct med...
Aims: To examine the relationship between costs of hyperglycaemia drug treatment and glycemic contro...
This is the author accepted manuscript. The final version is available from Springer Verlag via the ...
Introduction: Medication therapy for type 2 diabetes has become increasingly complex, and there are ...
This paper studies the features of metabolic parameters, diabetic complications and drug therapy of ...
Aims: Medication therapy for type 2 diabetes has become increasingly complex, and there is little re...
Objective: To examine the impact of type 2 diabetes on direct and indirect costs and to describe the...
Aims: to examine the relationship between costs of hyperglycemia drug treatment and glycemic control...
Objective To examine the impact of type 2 diabetes on direct and indirect costs and to describe the ...
Background: We aimed to estimate the proportion of patients with diabetes who achieved target glycem...
OBJECTIVEWe assessed the excess medical expenditures for adults newly diagnosed with diabetes, for u...
Aim: To analyse how healthcare utilisation, healthcare costs and health-related quality of life (HRQ...
We estimated healthcare costs associated with patients with type 2 diabetes compared with non-diabet...
Background: Type 2 diabetes mellitus is a common, chronic, and costly disease, and its prevalence is...
Objective To estimate the impact of glycaemic control and time since diabetes diagnosis on care cost...
Abstract Background The objective of this research is to quantify the association between direct med...
Aims: To examine the relationship between costs of hyperglycaemia drug treatment and glycemic contro...
This is the author accepted manuscript. The final version is available from Springer Verlag via the ...
Introduction: Medication therapy for type 2 diabetes has become increasingly complex, and there are ...
This paper studies the features of metabolic parameters, diabetic complications and drug therapy of ...
Aims: Medication therapy for type 2 diabetes has become increasingly complex, and there is little re...
Objective: To examine the impact of type 2 diabetes on direct and indirect costs and to describe the...
Aims: to examine the relationship between costs of hyperglycemia drug treatment and glycemic control...
Objective To examine the impact of type 2 diabetes on direct and indirect costs and to describe the ...
Background: We aimed to estimate the proportion of patients with diabetes who achieved target glycem...
OBJECTIVEWe assessed the excess medical expenditures for adults newly diagnosed with diabetes, for u...
Aim: To analyse how healthcare utilisation, healthcare costs and health-related quality of life (HRQ...
We estimated healthcare costs associated with patients with type 2 diabetes compared with non-diabet...
Background: Type 2 diabetes mellitus is a common, chronic, and costly disease, and its prevalence is...